Evidence map›Paper›PMID 36619378›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Adenoviral VEGF-D

Juho Pajula, Johanna Lähteenvuo, Markku Lähteenvuo, Krista Honkonen, Paavo Halonen, Olli-Pekka Hätinen, Antti Kuivanen, Minja Heikkilä, Jussi Nurro, Juha Hartikainen and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Juho PajulaA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Johanna LähteenvuoA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Markku LähteenvuoA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Krista HonkonenA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Paavo HalonenA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Olli-Pekka HätinenA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Antti KuivanenA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Minja HeikkiläA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Jussi NurroA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Juha HartikainenA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Seppo Ylä-HerttualaA.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiogenesisanimal models of human diseasecoronary artery diseasegene therapyVEGF-D

Identifiers

PMID36619378
PMCPMC9817830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.